Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 7.53
-0.02 (-0.26%)
Jul 29, 2025, 9:45 AM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 13.62 billion as of July 28, 2025. Its market cap has increased by 145.81% in one year.
Market Cap
13.62B
Enterprise Value
14.00B
Revenue
391.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.53
Market Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has increased from 11.84B to 13.62B, an increase of 15.04%. That is a compound annual growth rate of 4.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 13.62B | 203.97% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 271.47B |
| Hansoh Pharmaceutical Group Company | 215.83B |
| JD Health International | 155.85B |
| Innovent Biologics | 152.40B |
| Akeso | 135.17B |
| WuXi Biologics | 130.21B |
| Sino Biopharmaceutical | 121.08B |
| CSPC Pharmaceutical Group | 98.67B |